Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHF Research FoundationHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Mar 17 2025 | U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40% Industry News In The News Industry Read More Mar 16 2025 | HFSA President's Update: March 2025 HFSA News President's Updates Read More Mar 15 2025 | Advancing Heart Failure Care: Key Insights from HF Beat’s Expert Panel HFSA News Podcasts Read More Mar 11 2025 | Palliative Care and Heart Failure Highlighted in the March 2025 issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More Mar 7 2025 | scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease Industry News In The News Industry Read More Pagination First page « First Previous page ‹ Previous … Page 22 Page 23 Page 24 Page 25 Current page 26 Page 27 Page 28 Page 29 Page 30 … Next page Next › Last page Last »
Mar 17 2025 | U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40% Industry News In The News Industry Read More
Mar 15 2025 | Advancing Heart Failure Care: Key Insights from HF Beat’s Expert Panel HFSA News Podcasts Read More
Mar 11 2025 | Palliative Care and Heart Failure Highlighted in the March 2025 issue of Journal of Cardiac Failure (JCF) HFSA News Journal of Cardiac Failure Press Release Read More
Mar 7 2025 | scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX® Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease Industry News In The News Industry Read More
